Implantation, also known as nidation, is the stage in the mammalian embryonic development in which the blastocyst hatches, attaches, adheres, and invades into the endometrium of the female's uterus. Implantation is the first stage of gestation, and, when successful, the female is considered to be pregnant. An implanted embryo is detected by the presence of increased levels of human chorionic gonadotropin (hCG) in a pregnancy test. The implanted embryo will receive oxygen and nutrients in order to grow.
For implantation to take place the uterus must become receptive. Uterine receptivity involves much cross-talk between the embryo and the uterus, initiating changes to the endometrium. This stage gives a synchrony that opens a window of implantation that enables successful implantation of a viable embryo. The endocannabinoid system plays a vital role in this synchrony in the uterus, influencing uterine receptivity, and embryo implantation. The embryo expresses cannabinoid receptors early in its development that are responsive to anandamide (AEA) secreted in the uterus. AEA is produced at higher levels before implantation and is then down-regulated at the time of implantation. This signaling is of importance in the embryo-uterus crosstalk in regulating the timing of embryonic implantation and uterine receptivity. Adequate concentrations of AEA that are neither too high or too low, are needed for successful implantation.
There is an extensive variation in the type of Trophoblast, and structures of the placenta across the different species of mammals. Of the five recognised stages of implantation including two pre-implantation stages that precede placentation, the first four are similar across the species. The five stages are migration and hatching, pre-contact, attachment, adhesion, and invasion. The two pre-implantation stages are associated with the Pre-embryo.
In humans, following the stage of hatching that takes place around four to five days after fertilization, the process of implantation begins. By the end of the first week, the blastocyst is superficially attached to the uterine endometrium. By the end of the second week, implantation has completed.
During this migration the zygote undergoes a number of cell divisions that creates a ball of 16 compacted called a morula. The morula enters the uterus after three or four days, and as it does a cavity called the blastocoel is formed in the morula to produce the blastocyst. The blastocyst contains the inner cell mass that will go on to develop into the embryo proper, and an outer cell layer of trophoblasts that will develop into the extraembryonic membranes (fetal membranes).
The blastocyst is still enclosed in the egg-coat known as the zona pellucida, and for it to be able to implant into the uterine wall it must rid itself of this covering. This stage is known as zona hatching, and when there is sufficient dissolution the blastocyst is able to initiate the apposition stage of implantation. Lysis in the uterine cavity, as well as factors from the blastocyst itself are essential for the breakdown of the egg-coat. Mechanisms in the latter are indicated by the fact that the zona pellucida remains intact if an unfertilized egg is placed in the uterus under the same conditions.
Among the known molecular regulators that promote hatching are predominantly that are stimulated by various . The blastocyst also produces , both pro-inflammatory and anti-inflammatory, that have crucial roles during implantation and other stages of pregnancy. Both types of cytokines modulate the activity of proteases, including MMPs, plasminogen activators, and . It is unknown whether the cytokines involved in hatching are pro-inflammatory or anti-inflammatory, or which proteases are involved. However, it is well accepted that the pro-inflammatory cytokines are dominant during implantation. Cytokines are also present in the uterine milk which might regulate the development and function of the blastocyst but there is no evidence to support their involvement in hatching. Leukemia inhibitory factor (LIF) is a pro-inflammatory cytokine expressed in the endometrium during the luteal phase of the menstrual cycle, with the highest expression seen during the window of implantation. LIF plays a role in adhesion and invasion.
Assisted zona hatching may take place in assisted reproduction, where the zona pellucida may be artificially pierced to facilitate hatching. IVF-infertility.com
This adhering activity is by microvilli that are on the trophoblast. The trophoblast have binding fiber connections, laminin, collagen type IV, and integrins that assist in this adhesion process.
Mucin-16 is a transmembrane mucin expressed at the apical surface of uterine epithelia. This mucin prevents the blastocyst from implanting in an undesired located on the epithelium. Thus, MUC-16 inhibits cell-cell adhesion. Its removal during pinopode formation has been shown to facilitate trophoblast invasion in vitro.
The identity of the molecules on the trophoblast and the endometrial epithelia that mediate the initial interaction between the two remain unidentified. However, a number of research groups have proposed that MUC1, a member of the mucin family of glycosylated proteins, is involved. MUC1 is a transmembrane glycoprotein expressed at the apical surface of endometrial epithelial cells during the window of implantation in humans and has been shown to be differentially expressed between fertile and infertile subjects during this time. MUC1 displays carbohydrate moieties on its extracellular domain that are ligands of L-selectin, a cell adhesion molecule on the surface of trophoblast cells. An in vitro model of implantation gave evidence to support the hypothesis that L-selectin mediates apposition of the blastocyst to the uterine epithelium by interacting with its ligands.
When the syncytiotrophoblast reaches the basal membrane beneath the , it dislodges them to further invade into the uterine stroma. Dislodging is accomplished by degrading the cell adhesion molecules (CAMs) that link the decidual cells, and the associated extracellular matrix. Degradation is achieved by the secretion of tumor necrosis factor-alpha from the syncytiotrophoblast, which inhibits the expression of CAMs and beta-catenin. The extracellular matrix is degraded by metalloproteinases such as collagenases, gelatinases and matrix metalloproteinases, and by . The collagenases digest Type-I collagen, Type-II collagen, III, VII and X collagen. The gelatinases exist in two forms; one digesting Type-IV collagen and one digesting gelatin. The extracellular matrix is degraded by serine endopeptidases and metalloproteinases. The syncytiotrophoblast can then invade into the endometrium taking the embryo with it where it becomes embedded. Eventually, the syncytiotrophoblast comes into contact with maternal blood and forms chorionic villi – the beginning of placentation. Following invasion, the breach in the uterine epithelium made by the blastocyst's entry is sealed by a Fibrin. The fibrin plug is a coagulation of a blood clot and cellular debris.
During invasion the blastocyst secretes factors for a multitude of purposes. It secretes several autocrine factors, targeting itself and stimulating it to further invade the endometrium. Human chorionic gonadotropin (hCG) is an autocrine growth factor for the blastocyst, while insulin-like growth factor 2, stimulates its invasiveness.
Human chorionic gonadotropin not only acts as an immunosuppressive, but also signals to the mother that she is pregnant, preventing luteolysis of the corpus luteum and menstruation by sustaining the function of the corpus luteum. Secretions loosen decidual cells from each other, prevent the embryo from being rejected by the mother, trigger the final decidualization and prevent menstruation. Preimplantation factor is secreted by trophoblast cells ahead of placenta formation.
Successful implantation is co-dependent on the viability of the embryo, and the receptivity of the uterus. A critical involved factor is the developmental Synchronization between the embryo and the uterus. The synchrony gives a short period of receptivity known as the window of implantation, and involves much crosstalk between the blastocyst and the endometrium at this stage.
The endocannabinoid system plays a vital role in this synchrony in the uterus, influencing uterine receptivity, and embryo implantation. The embryo expresses cannabinoid receptors early in its development that are responsive to anandamide (AEA) secreted in the uterus. This signaling is of importance in the embryo-uterus crosstalk in regulating the timing of embryonic implantation and uterine receptivity. Adequate concentrations of AEA that are neither too high or too low, are needed for successful implantation. IL-6 and FAAH are both crucial for uterine receptivity and together with AEA there is seen to be a link with adequate endometrial thickness that sustains pregnancy.
During adhesion the cross-talk is conveyed by receptor-ligand-interactions, both integrin-matrix and proteoglycan ones. Proteoglycan receptors are found on the surface of the decidua, and their counterparts, the proteoglycans, are found around the trophoblast cells of the blastocyst. This ligand-receptor system is also present just at the implantation window. The blastocyst signals to the endometrium to adapt further to its presence, for example by changes in the cytoskeleton of decidual cells. This, in turn, dislodges the decidual cells from their connection to the underlying basal lamina, which enables the blastocyst to perform the succeeding invasion.
The endometrial microbiome has been indicated as having an important role in successful implantation in controlling endometrial cell function, and the function of the local immunity system that prevents pathogen growth. This is associated with the secretion of protective substances.
Their development is enhanced by progesterone, and inhibited by estrogens. During the window of implantation, cell to cell adhesion is inhibited by MUC1 a cell surface glycoprotein, belonging to the glycocalyx. The pinopodes are taller than the microvilli and protrude through the glycocalyx enabling direct contact with the adhering trophoblast. The most important attribute of pinopodes is this removal of glycoproteins from the cell surfaces of the uterine epithelial cells. MUC16 has also been shown to disappear from the cell surfaces with the development of the pinopodes.
Some studies have reported that pinopodes entrap cilia, which prevents embryo movement, and during implantation allows close contact and adherence of the embryo.
Pinopodes bring uterine fluid and its macromolecules into the cells by the process of endocytosis. This decreases the volume of the uterus, taking the walls closer to the blastocyst floating in it. Thus, the period of active pinopodes might limit the implantation window. Pinopodes continue to absorb fluid, removing most of it during the early stages of implantation.
Furthermore, the surface of the endometrium produces a kind of rounded cells, which cover the whole area toward the uterine cavity. This happens about 9 to 10 days after ovulation. These cells are called , which emphasises that the whole layer of them is shed off in every menstruation if no pregnancy occurs, just as leaves of deciduous trees. The uterine glands, on the other hand, decrease in activity and degenerate around 8 to 9 days after ovulation in absence of pregnancy.
The decidual cells originate from the stromal cells that are always present in the endometrium, and make up a new layer, the decidua. The rest of the endometrium, in addition, expresses differences between the luminal and the basal sides. The luminal cells form the stratum compactum of the endometrium, in contrast to the basalolateral stratum spongiosum, which consists of the rather spongy stromal cells.
The embryo releases serine proteases which causes the epithelial cell membrane to Depolarization and activates the epithelial sodium channel. This triggers an influx of calcium ions (Ca2+) and phosphorylation of CREB. Phosphorylation of CREB upregulates the expression of COX2, which leads to the release of prostaglandin E2 (PGE2) from epithelial cells. PGE2 acts on the stroma cells activating cAMP-related pathways in stromal cell leading to decidualization.
The compacta and spongiosa layers are still observable beneath the decidua in pregnancy. The glands of the spongiosa layer continue to secrete during the first trimester, when they degenerate. However, before that disappearance, some glands secrete unequally much. This phenomenon of hypersecretion is called the Arias-Stella phenomenon, after the pathologist Javier Arias-Stella.
Inadequate uterine receptivity may be caused by abnormal cytokine and hormonal signaling as well as epigenetic alterations. Recurrent implantation failure is a cause of female infertility. Therefore, can be improved by optimizing endometrial receptivity for implantation. Evaluation of implantation markers may help to predict pregnancy outcome and detect occult implantation deficiency. As part of the organ-on-a-chip program, an endometrium-on-a-chip has been developed to model the functioning of the endometrium that could more clearly identify causes of implantation failure. have also been developed to model the endometrium and its role in implantation.
In women with more than three implantation failures in assisted reproduction, a review of several small randomized controlled studies estimated that the use of adjunct low molecular weight heparin improves live birth rate by approximately 80%. Luteal support can include the use of progesterone and human chorionic gonadotropin (hCG) to improve the chances of a successful implantation.
Invasion
Extravillous trophoblasts
Secretions
Immunosuppressive
Other factors
Uterus receptivity
Window of implantation
Pinopodes
Predecidualization
Decidualization
Parts of decidua
Decidua throughout pregnancy
Uterine glands
Not only the lining of the uterus transforms, but the secretion from its uterine gland changes. This change is induced by increased levels of progesterone from the corpus luteum. The target of the secretions is the embryoblast, and has several functions on it.
>'''Proteins, glycoproteins and peptides'''
'''Matrix-associated:''' [[Fibronectin]] [[Laminin]] [[Entactin]] [[Type-IV collagen]] [[Heparan sulfate]] [[Proteoglycan]] [[Integrins]] – '''Others:''' [[Mucin]]s [[Prolactin]] [[IGFBP]]-1 [[Glycodelin]] Endometrial protein 15 [[Albumin]] [[Beta-Lipoprotein]] [[Relaxin]] Fibroblast growth factor 1 Fibroblast growth factor 2 Pappalysin-1 Stress response protein 27 (SRP-27) CA-125 [[Beta-endorphin]] Leu-[[enkephalin]] Di[[amine oxidase]] Tissue plasminogen activator [[Renin]] Progesterone-dependent carbonic anhydrase [[Lactoferrin]]
Nourishment
Growth and implantation
Clinical significance
Implantation failure
Zinc deficiency
Implantation bleeding
See also
Books
Further reading
External links
|
|